Overview
DCM progressively weakens the left ventricular muscle, sometimes involving both ventricles, with chamber enlargement and reduced contraction. Less blood is pumped with each beat. Inadequate output can cause exercise intolerance, breathing difficulty and fainting.
A long occult phase is characteristic. A dog may appear unchanged despite an enlarged, poorly contracting left ventricle on ultrasound for months or years. Without detection, the first recognized event may be breathing difficulty, ascites, fainting or sudden death.
Predisposed breeds
DCM is reported more frequently in the following large and giant breeds. Strong genetic predisposition in some breeds supports monitoring from a younger age.
- Doberman Pinscher — a major predisposed breed; occult arrhythmias make Holter monitoring important
- Boxer — possible distinct cardiomyopathy requiring emphasis on rhythm assessment
- Great Dane, Irish Wolfhound, Newfoundland and Saint Bernard
- Some medium-sized breeds, including American and English Cocker Spaniels
- Other middle-aged and older large dogs
DCM can rarely affect small dogs, but MMVD should first be considered when left-heart enlargement is found in a small dog.
What signs should I watch for?
Occult DCM may have almost no outward signs and little or no murmur. The following signs warrant imaging andECG assessment.
- Tiring unusually quickly on familiar walks, with slower recovery
- Repeated increases above the usual sleeping respiratory rate
- Brief collapse or unsteadiness after excitement, exercise or coughing (syncope)
- Progressive abdominal swelling suggestive of fluid accumulation (ascites)
- Reduced appetite, weight loss and low energy
- Pale or bluish tongue or gums
The occult phase progresses without symptoms
Owners may notice almost no outward change. For predisposed breeds such as Dobermans and Boxers, regular ultrasound and Holter assessment before symptoms offer the best opportunity to detect disease before an abrupt clinical event.
Diagnostic steps
Diagnosis establishes ventricular dilation and impaired contraction, then assesses concurrent arrhythmias.
-
Auscultation + Resting respiratory rate
Listen for murmurs, gallops and arrhythmias, and review home SRR records. Imaging remains relevant because auscultation can be nearly normal during the occult phase.
-
Chest X-rays (heart enlargement)
Assess heart size (VHS), left atrial and ventricular enlargement, pulmonary venous congestion, edema and abdominal fluid accumulation.
-
Echocardiography (ventricular dilation and contraction)
Measure ventricular dimensions, atrial size and contraction indices such as FS and EF. This provides core diagnostic evidence, helps distinguish MMVD and assesses concurrent valve leakage.
-
Holter monitoring (occult arrhythmias, particularly in Dobermans)
A 24-hour ECG assesses the frequency and pattern of occult arrhythmias, especially ventricular premature complexes (VPCs). In Dobermans, these may precede symptoms, making the test particularly important.
-
Blood tests + NT-proBNP (when indicated)
Kidney and liver function and electrolytes provide a medication baseline. NT-proBNP can support risk assessment during the occult phase.
Occult and clinical phases
DCM management distinguishes the occult phase from overt congestive heart failure. Phase affects medication choices and monitoring intervals.
| Stage | Condition | Treatment approach |
|---|---|---|
| Occult phase | Ultrasound abnormalities without symptoms | Regular assessment and consideration of medication in selected patients, including Dobermans |
| Clinical phase (overt CHF) | Heart failure signs, including breathing difficulty and ascites | Combination medication + Emergency planning + Closer monitoring |
This table summarizes the general clinical course for owners. Individual ultrasound and Holter findings guide the veterinarian's decisions.
Treatment and care by stage
Care aims to prolong the symptom-free phase and promptly stabilize clinical disease. We use a stage-based approach.
Medication during the occult phase
When ultrasound confirms ventricular dilation and poor contraction, inotropic treatment may be considered in selected breeds, particularly Dobermans, to delay clinical disease. Kidney function and electrolytes are monitored during treatment.
Combination treatment during the clinical phase
Pulmonary edema, ascites or breathing difficulty may require combinations of diuretics, inotropes, vasodilators and ACE inhibitors. Significant arrhythmias also prompt consideration of antiarrhythmics.
Home monitoring — Resting respiratory rate (SRR)
Count breaths for one minute while your pet sleeps and compare with the usual rate. Contact the veterinarian if faster breathing recurs and agree on individual contact thresholds. For labored or open-mouth breathing, go straight to the nearest 24-hour emergency veterinary hospital regardless of the count.
Complications and concurrent conditions
We regularly track kidney and liver function and electrolytes during long-term medication. Orthopedic and endocrine disease in older large dogs also affects medication and activity plans and is assessed together.
Frequently asked questions
Is DCM testing needed without symptoms?
Is it reassuring if no murmur is heard?
Why is Holter monitoring needed?
Can DCM be cured?
At what age should a predisposed breed be screened?
What if symptoms suddenly worsen?
References
These external resources explain canine DCM and its assessment. They do not define our services or an individual prescription.
- North Carolina State Veterinary Hospital — Canine Dilated Cardiomyopathy (opens in a new window)
- ESVC — Doberman DCM screening guidelines (Wess et al., 2017). Specific to Dobermans (opens in a new window)
- Texas A&M Veterinary Hospital — Measuring respiratory rate at home (PDF; opens in a new window)